The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Colistin: new lessons on an old antibiotic
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Cruz, D. N., Antonelli, M., Fumagalli, R., Foltran, F., Brienza, N., Donati, A., Malcangi, V., Petrini, F., Volta, G., Bobbio Pallavicini, F. M., et al. (2009) · JAMA · doi:10.1001/jama.2009.856 · Cited by 832
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Structure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Polymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Paul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 724
Self-citationLevin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Schwaber, M. J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-07 · Cited by 483
Hirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
Nation, R. L., & Li, J. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328332e672 · Cited by 443
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
THE PROPERTIES AND MODE OF ACTION OF THE POLYMYXINS
Newton, B. A. (1956) · Bacteriological Reviews · doi:10.1128/br.20.1.14-27.1956 · Cited by 349
Zhang, L., Dhillon, P., Yan, H., Farmer, S., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3317-3321.2000 · Cited by 349
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
Cruz, D. N., Perazella, M. A., Bellomo, R., de Cal, M., Polanco, N., Corradi, V., Lentini, P., Nalesso, F., Ueno, T., Ranieri, V. M., et al. (2007) · Critical Care · doi:10.1186/cc5780 · Cited by 347
Pogue, J. M., Lee, J., Marchaim, D., Yee, V., Zhao, J. J., Chopra, T., Lephart, P., & Kaye, K. S. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir611 · Cited by 327
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Leibovici, L., Paul, M., Poznanski, O., Drucker, M., Samra, Z., Konigsberger, H., & Pitlik, S. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1127 · Cited by 280
Self-citationMarkou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Antoniadou, A., Kontopidou, F., Poulakou, G., Koratzanis, E., Galani, I., Papadomichelakis, E., Kopterides, P., Souli, M., Armaganidis, A., & Giamarellou, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl562 · Cited by 273
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
Self-citationKo, K. S., Suh, J. Y., Kwon, K. T., Jung, S.-I., Park, K.-H., Kang, C. I., Chung, D. R., Peck, K. R., & Song, J.-H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm305 · Cited by 262
Linden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
Falagas, M. E., Rizos, M., Bliziotis, I. A., Rellos, K., Kasiakou, S. K., & Michalopoulos, A. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-1 · Cited by 242
Betrosian, A. P., Frantzeskaki, F., Xanthaki, A., & Douzinas, E. E. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.002 · Cited by 230
Petrosillo, N., Ioannidou, E., & Falagas, M. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02061.x · Cited by 213
Rattanaumpawan, P., Lorsutthitham, J., Ungprasert, P., Angkasekwinai, N., & Thamlikitkul, V. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq360 · Cited by 211
Michalopoulos, A., Kasiakou, S. K., Mastora, Z., Rellos, K., Kapaskelis, A. M., & Falagas, M. E. (2004) · Critical Care · doi:10.1186/cc3020 · Cited by 209
Kofteridis, D. P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D., & Samonis, G. (2010) · Clinical Infectious Diseases · doi:10.1086/657242 · Cited by 207
Gordon, N. C., Png, K., & Wareham, D. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00922-10 · Cited by 195
Michalopoulos, A., Fotakis, D., Virtzili, S., Vletsas, C., Raftopoulou, S., Mastora, Z., & Falagas, M. E. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2007.10.011 · Cited by 191
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
Ouderkirk, J. P., Nord, J. A., Turett, G. S., & Kislak, J. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2659-2662.2003 · Cited by 188
Reina, R., Estenssoro, E., Sáenz, G., Canales, H. S., Gonzalvo, R., Vidal, G., Martins, G., Das Neves, A., Santander, O., & Ramos, C. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2691-4 · Cited by 186
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Poudyal, A., Howden, B. P., Bell, J. M., Gao, W., Owen, R. J., Turnidge, J. D., Nation, R. L., & Li, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn425 · Cited by 185
Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy
Hawley, J. S., Murray, C. K., & Jorgensen, J. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-07 · Cited by 183
Dudhani, R. V., Turnidge, J. D., Nation, R. L., & Li, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq226 · Cited by 181
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
DeRyke, C. A., Crawford, A. J., Uddin, N., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-09 · Cited by 178
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Korbila, I. P., Michalopoulos, A., Rafailidis, P. I., Nikita, D., Samonis, G., & Falagas, M. E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03040.x · Cited by 170
Bengoechea, J. A., & Skurnik, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01956.x · Cited by 169
Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., Belabbes, H., & Benbachir, M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.019 · Cited by 165
Matthaiou, D. K., Michalopoulos, A., Rafailidis, P. I., Karageorgopoulos, D. E., Papaioannou, V., Ntani, G., Samonis, G., & Falagas, M. E. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181652fae · Cited by 163
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 163
Johansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.02.003 · Cited by 161
Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., & Paul, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm193 · Cited by 158
Self-citationBinding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa
Peterson, A. A., Hancock, R. E. W., & McGroarty, E. J. (1985) · Journal of Bacteriology · doi:10.1128/jb.164.3.1256-1261.1985 · Cited by 156
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Meletis, G., Tzampaz, E., Sianou, E., Tzavaras, I., & Sofianou, D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr007 · Cited by 154
Yau, W., Owen, R. J., Poudyal, A., Bell, J. M., Turnidge, J. D., Yu, H. H., Nation, R. L., & Li, J. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.11.002 · Cited by 152
de Oliveira, M. S., do Prado, G. V. B., Costa, S. F., Grinbaum, R. S., & Levin, A. S. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn128 · Cited by 149
Me, J.-M., Pichardo-Guerrero, C., Márquez-Rivas, J., Martín-Lozano, D., Prados, T., & Pachón, J. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-001-0680-2 · Cited by 145
Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics
Mogi, T., & Kita, K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0129-9 · Cited by 139
Tan, C.-H., Li, J., & Nation, R. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01571-06 · Cited by 138
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
Barnett, M., Bushby, S. R. M., & Wilkinson, S. (1964) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1964.tb01610.x · Cited by 134
Bergen, P. J., Tsuji, B. T., Bulitta, J. B., Forrest, A., Jacob, J., Sidjabat, H. E., Paterson, D. L., Nation, R. L., & Li, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05298-11 · Cited by 128
Bergen, P. J., Forrest, A., Bulitta, J. B., Tsuji, B. T., Sidjabat, H. E., Paterson, D. L., Li, J., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05028-11 · Cited by 128
Koomanachai, P., Tiengrim, S., Kiratisin, P., & Thamlikitkul, V. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.09.011 · Cited by 119
Colistin pharmacokinetics: the fog is lifting
Couet, W. R., Grégoire, N., Marchand, S., & Mimoz, O. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03667.x · Cited by 111
Montero, M., Horcajada, J. P., Sorlí, L., et al. (2009) · Infection · doi:10.1007/s15010-009-8342-x · Cited by 95
Falagas, M. E., Kasiakou, S. K., Kofteridis, D. P., Roditakis, G., & Samonis, G. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0191-2 · Cited by 95
Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials
Marcus, R., Paul, M., Elphick, H., & Leibovici, L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.029 · Cited by 84
Self-citationVentilator-associated pneumonia due to colistin susceptible-only microorganisms
Ríos, F. G., Luna, C. M., Maskin, B. C., Valiente, A., Lloria, M., Gando, S., Sosa, C., Baquero, S., Llerena, C., Petrati, C., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00156906 · Cited by 83
Gounden, R., Bamford, C., van Zyl-Smit, R. N., Cohen, K., & Maartens, G. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-26 · Cited by 80
Antimicrobial Agents and the Central Nervous System
Everett, D., & Strausbaugh, L. J. (1980) · Neurosurgery · doi:10.1227/00006123-198006000-00016 · Cited by 77
Pneumonia Due to Pseudomonas aeruginosa
Sun, H., Fujitani, S., Quintiliani, R., & Yu, V. L. (2011) · CHEST Journal · doi:10.1378/chest.10-0167 · Cited by 73
In VitroInteraction of Colistin and Rifampin on Multidrug-ResistantPseudomonas aeruginosa
Giamarellos‐Bourboulis, E. J., Sambatakou, H., Galani, I., & Giamarellou, H. (2003) · Journal of Chemotherapy · doi:10.1179/joc.2003.15.3.235 · Cited by 73
Souli, M., Rekatsina, P. D., Chryssouli, Z., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-08 · Cited by 57
Inhaled colistin as monotherapy for multidrug-resistant gram (−) nosocomial pneumonia: A case series
Falagas, M. E., Siempos, I. Ι., Rafailidis, P. I., Korbila, I. P., Ioannidou, E., & Michalopoulos, A. S. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.018 · Cited by 56
Lin, C.-C., Liu, T.-C., Kuo, C.-F., Liu, C.-P., & Lee, C.-M. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60050-3 · Cited by 56
Falagas, M. E., & Kasiakou, S. K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00101-06 · Cited by 45
Lim, S.-K., Lee, S., Choi, S., Choi, J., Kim, S., Jeong, J., Choi, S., Woo, J. H., & Kim, Y. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.3.325 · Cited by 44
International Differences in the Treatment of Sepsis
Kellum, J. A., & Uchino, S. (2009) · JAMA · doi:10.1001/jama.2009.850 · Cited by 39
Majumdar, A., & Das, P. S. (2008) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.45074 · Cited by 34
Rogers, M. J., & Cohen, J. (1986) · Infection · doi:10.1007/bf01644448 · Cited by 27
Μάρκου, Ν., Fousteri, M., Markantonis, S. L., Boutzouka, E. G., Tsigou, E., & Baltopoulo, G. (2011) · CHEST Journal · doi:10.1378/chest.10-1860 · Cited by 24
Cited by
Poirel, L., Jayol, A., & Nordmann, P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00064-16 · Cited by 1,447
Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-17 · Cited by 704
Molecular mechanisms related to colistin resistance in Enterobacteriaceae
Aghapour, Z., Gholizadeh, P., Ganbarov, K., bialvaei, A. Z., Mahmood, S. S., Tanomand, A., Yousefi, M., Asgharzadeh, M., Yousefi, B., & Samadi Kafil, H. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s199844 · Cited by 320
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
Poirel, L., Jayol, A., Bontron, S., Villegas, M.-V., Ozdamar, M., Turkoglu, S., & Nordmann, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku323 · Cited by 302
Current Update on Intrinsic and Acquired Colistin Resistance Mechanisms in Bacteria
Gogry, F. A., Siddiqui, M. T., Sultan, I., & Haq, Q. M. R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.677720 · Cited by 265
Metadata
- Authors
- Yahav, D., Farbman, L., Leibovici, L., & Paul, M.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 18
- Issue
- 1
- Pages
- 18-29
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W1628591093
- Cited by
- 259
- References
- 87
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.